BioFire Diagnostics

What BioFire Diagnostics does

BioFire Diagnostics, LLC is a wholly-owned subsidiary of bioMérieux SA (Euronext: BIM) and operates as bioMérieux's Global Center of Excellence for Molecular Diagnostics, headquartered in Salt Lake City, Utah with 1,001–5,000 employees. The company develops and commercializes multiplex PCR-based syndromic infectious disease testing on the BIOFIRE FilmArray System, including the FilmArray 2.0, FilmArray Torch, and the 2024-launched SPOTFIRE point-of-care platform. BioFire sells a menu of FDA-cleared and IVDR-conformant assay panels covering respiratory, blood culture identification, gastrointestinal, meningitis/encephalitis, pneumonia, and joint infection syndromes, plus specialty panels (tropical fever, veterinary, defense).

The company monetizes via a razor-and-blade model: instruments are placed with limited nontransferable licenses while the proprietary single-use pouches (sold in 6-pack and 30-pack formats) generate recurring consumable revenue across hospital labs, reference labs, urgent care centers, and government/defense customers. Go-to-market combines enterprise field sales to hospital systems, inside sales and quote-based pricing, technical/customer support infrastructure, and clinical education programs (P.A.C.E., ACCME-accredited CME). Distribution is global, leveraging bioMérieux's commercial scale in the U.S., EU, and international markets.

In 2025, BioFire rebranded from a corporate subsidiary to a product franchise brand under the unified bioMérieux identity ("BF to bMx Transition"), consolidating brand architecture while preserving the FilmArray and SpotFire product lines, the Syndromic Trends data service, VILINK cloud connectivity, and FIREWORKS analytics. The intellectual property estate is broad, with granted U.S. and foreign patents across instruments and panels, supporting a defensible regulatory and technology moat in syndromic molecular diagnostics.

Name

BioFire Diagnostics

Legal name

BioFire Diagnostics, LLC

Website

https://biofiredx.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

501–1,000 employees

Short description

BioFire Diagnostics, a wholly-owned subsidiary of bioMérieux SA, develops FDA-cleared multiplex PCR syndromic testing systems (FilmArray and SPOTFIRE) and panels that deliver infectious disease diagnostics in about one hour to hospital laboratories, reference labs, urgent care centers, and government/defense customers worldwide.

Ownership category

akta.pro rank

Product category

Molecular Diagnostics — Syndromic Infectious Disease Testing

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels) (HLAAALAC)

akta.pro secondary industries

Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays) (HLAAALAL), Multiplex Syndromic POCT Panels (Respiratory/GI/meningitis panels) (HLAHAOAJ)

Keywords

• Molecular diagnostics
• Syndromic testing
• Infectious disease detection
• Multiplex PCR assays
• Clinical laboratory instruments

Headquarters

HQ city

Salt Lake City

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Instrument Systems: Sale of BIOFIRE System instruments including FilmArray 2.0, Torch System, and SpotFire System. Instruments are sold to clinical laboratories and healthcare facilities with associated limited, nontransferable instrument licenses.
2. Diagnostic Panels and Consumables: Recurring revenue from sale of FDA-cleared assay panels (pouches/kits) including Respiratory 2.1, Blood Culture Identification 2, Gastrointestinal, Meningitis/Encephalitis, Pneumonia, and Joint Infection panels. Panels are sold in pack sizes (6-pack, 30-pack) and require ongoing purchase for each test performed.
3. Service and Support: Technical support, customer service, and product support including extended warranty plans, standard limited warranties, and ongoing customer technical support for instrument maintenance and troubleshooting.
4. Licensing Royalties: Purchase of instruments and kits includes limited, nontransferable licenses under specific claims of U.S. patents and foreign counterparts for use according to specified protocols.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

Core offering

BioFire Diagnostics manufactures and sells multiplex PCR-based syndromic infectious disease testing systems — the BIOFIRE FILMARRAY System (including FilmArray 2.0 and Torch instruments) and the BIOFIRE SPOTFIRE point-of-care system — together with FDA-cleared single-use assay panels (respiratory, blood culture ID, gastrointestinal, meningitis/encephalitis, pneumonia, joint infection) and supporting connectivity/data software. Instruments are sold or licensed to clinical laboratories and hospitals, with recurring revenue from consumable pouches required for every test.

Product overview

BioFire Diagnostics, now operating as a product franchise brand under bioMérieux, offers the BIOFIRE FilmArray System as its core molecular diagnostics platform for syndromic infectious disease testing. The portfolio consists of the FilmArray System (including FilmArray 2.0 and FilmArray Torch instruments), the SPOTFIRE System for point-of-care testing, and multiple FDA-cleared multiplex PCR panels (Respiratory 2.1, Respiratory EZ, Blood Culture ID 2, Gastrointestinal, Meningitis/Encephalitis, Pneumonia, Joint Infection). The company also provides connectivity solutions (VILINK cloud platform, FilmArray Link LIS software), data services (BioFire Syndromic Trends), and specialized offerings for veterinary (VETFIRE) and defense (BioFire Defense) markets. All products leverage multiplex PCR technology for comprehensive syndromic testing with results in approximately one hour.

Differentiator

Problem solved

Functional benefit

Brands

• BIOFIRE FILMARRAY: Multiplex PCR syndromic testing system for infectious disease diagnostics
• BIOFIRE SPOTFIRE
• WATCHFIRE
• VETFIRE
• VILINK

Products and services

• BIOFIRE FILMARRAY System Multiplex PCR-based syndromic testing platform that delivers infectious disease diagnostic results in approximately one hour with about two minutes of hands-on time, used by clinical laboratories and hospitals to test for multiple pathogens simultaneously.
• BIOFIRE SPOTFIRE System A compact, FDA-cleared molecular diagnostics platform for rapid syndromic infectious disease testing at point-of-care settings such as urgent care centers, outpatient clinics, and physician offices.
• BioFire Respiratory 2.1 (RP2.1) Panel FDA-cleared multiplex PCR panel run on the BIOFIRE FILMARRAY System to detect viruses and bacteria causing respiratory infections in approximately one hour.
• BioFire Respiratory EZ Panel Streamlined multiplex respiratory pathogen panel for the FilmArray System, designed for simpler workflow and faster adoption in routine testing.
• BioFire Blood Culture Identification 2 (BCID2) Panel FDA-cleared multiplex PCR panel for the FilmArray System that identifies bacteria, yeasts, and antimicrobial resistance genes from positive blood cultures to support sepsis management.
• BioFire Gastrointestinal (GI) Panel FDA-cleared multiplex PCR panel for the FilmArray System that detects viruses, bacteria, parasites, and yeasts causing gastroenteritis from a single stool sample.
• BioFire Meningitis/Encephalitis (ME) Panel FDA-cleared multiplex PCR panel for the FilmArray System that detects bacteria, viruses, and fungi causing meningitis and encephalitis from cerebrospinal fluid.
• BioFire Pneumonia Panel FDA-cleared multiplex PCR panel for the FilmArray System that detects respiratory bacteria and antibiotic resistance markers associated with pneumonia from sputum or bronchoalveolar lavage samples.
• BioFire Joint Infection (JI) Panel FDA-cleared multiplex PCR panel for the FilmArray System that detects bacteria and fungi causing joint infections from synovial fluid.
• BIOFIRE SPOTFIRE Respiratory/Sore Throat Panel FDA-cleared multiplex panel for the SPOTFIRE point-of-care System that simultaneously tests for respiratory pathogens and sore throat pathogens.
• BioFire Syndromic Trends Epidemiological data service that aggregates and analyzes syndromic testing results from BIOFIRE Systems to deliver population-level infectious disease trend insights for healthcare systems and public health.
• VILINK Connectivity Solution Cloud connectivity solution for BIOFIRE Systems that enables remote system monitoring, data management, and over-the-air system updates across deployed FilmArray and SPOTFIRE instruments.
• BIOFIRE FilmArray Link Software Software that enables bidirectional integration of FilmArray systems with laboratory information systems (LIS) for automated result transmission and workflow management.
• BIOFIRE FIREWORKS Data visualization and analysis software that helps laboratories and healthcare providers interpret and report results from BIOFIRE diagnostic testing systems.
• BioFire Defense Products Military and biodefense diagnostic product line including the FilmArray NGDS BT-E Assay, Warrior Panel, Sentinel Panel, BioThreat-E Panel, and COVID-19 Test for biothreat identification by DoD and allied defense customers.
• VETFIRE Equine Respiratory Panel Veterinary diagnostic panel that extends FilmArray syndromic testing to detect respiratory pathogens in horses.
• WATCHFIRE Respiratory (R) Panel International-market respiratory pathogen panel offered on FilmArray systems for syndromic testing outside the U.S.
• WATCHFIRE Gastrointestinal (G) Panel International-market gastrointestinal pathogen panel offered on FilmArray systems for syndromic testing outside the U.S.
• BIOFIRE Tropical Fever Panel Multiplex panel for detection of pathogens causing tropical fevers, expanding BioFire's syndromic testing portfolio to emerging infectious disease markets.

Quantifiable outcome

• Results delivered in approximately one hour compared to traditional methods taking days
• +2 more outcomes

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature6 records

Partnerships

One partnership is on record.

• ThalescoreTechnology or IntegrationBioMérieux maintains a valued partnership with Thales for cybersecurity technology. Thales contributes to bioMérieux's secure product development through collaboration between Patrick Lethenet, VP System Development Clinical Unit at bioMérieux, and Christian Rivierre, VP systems & software engineering at Thales. This partnership supports delivery of secure diagnostic products.

Scale indicators3 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• Hologic: Hologic's Panther Fusion system offers modular PCR testing in hospital and reference labs, providing an alternative multiplex platform to FilmArray for respiratory and other infectious disease panels.
• Roche Diagnostics: Roche's cobas Liat system provides rapid PCR at point-of-care (including Strep A, Flu, RSV) and the cobas 6800/8800 systems serve central labs, both adjacent to BioFire's syndromic franchise and now augmented by the GenMark ePlex acquisition.
• Abbott Molecular: Abbott's m2000 and Alinity m systems deliver molecular infectious disease testing in hospital and reference labs, providing broader menu-based PCR competition to BioFire's syndromic panels.
• Becton Dickinson (BD): BD's MAX System and broader molecular diagnostics portfolio compete with FilmArray in the hospital clinical laboratory segment, though BD is a broader incumbent across multiple diagnostics categories rather than a syndromic pure-play.
• QuidelOrtho: QuidelOrtho's Sofia and Triage platforms target rapid immunoassay and molecular diagnostics at point-of-care and clinical labs, including respiratory pathogen testing that competes with SPOTFIRE.

Direct peers

• Cepheid (Danaher): Cepheid's GeneXpert Xpress and Infinity systems compete head-to-head with FilmArray and SPOTFIRE in syndromic respiratory, GI, and meningitis/encephalitis panels, with a similar cartridge-based PCR business model and hospital lab customer base.
• QIAGEN: QIAGEN's QIAstat-Dx Respiratory Panel and growing syndromic menu directly compete with BioFire FilmArray panels, targeting the same hospital clinical laboratory customers with multiplex PCR cartridges.
• GenMark Diagnostics (Roche): GenMark's ePlex system (now under Roche) offers syndromic molecular panels for respiratory, blood culture identification, and GI testing that directly overlap with BioFire's FilmArray menu and target hospital labs.
• DiaSorin (Luminex legacy): DiaSorin acquired Luminex, whose Verigene and NxTAG platforms deliver syndromic and respiratory molecular testing that competes with FilmArray in clinical laboratory settings.

Emerging players

• Mesa Labs (BioFire Defense peer): Mesa Labs and other biodefense-focused diagnostics vendors compete with BioFire Defense products (NGDS BT-E, BioThreat-E) for government and military biothreat detection contracts.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/BioFireDX
• YouTubeyoutube.com/c/BioFireDX
• Facebookfacebook.com/biofirediagnostics
• LinkedInlinkedin.com/company/biofire-diagnostics-inc-

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds3 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioFire Diagnostics